D1 Dopamine Receptor is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Gs-coupled dopamine receptor mediating motor control and reward
The DRD1 protein is encoded by the DRD1 gene and is a member of the Dopamine receptor family (Class A GPCR). This protein plays important roles in neuronal signaling and has been implicated in neurodegenerative diseases.
| Attribute | Value |
|---|---|
| Protein Name | D1 Dopamine Receptor |
| Gene | DRD1 |
| UniProt ID | P21728 |
| PDB Structures | 5G53, 6WIV |
| Molecular Weight | 49 kDa |
| Subcellular Localization | Plasma membrane, postsynaptic densities, lipid rafts |
| Protein Family | Dopamine receptor family (Class A GPCR) |
The DRD1 protein contains seven transmembrane helices typical of class A GPCRs, with an extracellular N-terminus and intracellular C-terminus. The ligand-binding pocket is located within the transmembrane domain. Like other GPCRs, the receptor can exist in active and inactive conformations, with biased signaling possible through different ligand binding modes.
The D1 dopamine receptor (DRD1) is the most abundant dopamine receptor in the brain and couples to Gs/olf proteins, stimulating adenylyl cyclase and increasing cAMP levels. D1 receptors are essential for motor control through the direct pathway of the basal ganglia, where they promote movement initiation. In the prefrontal cortex and hippocampus, D1 signaling is critical for working memory, attention, and long-term memory consolidation. D1 receptors undergo desensitization and internalization, processes that may be altered in neurodegenerative diseases. The receptor also activates DARPP-32, a key signaling molecule that modulates protein phosphatase-1 activity.
Parkinson's Disease (degeneration of dopaminergic neurons reduces D1 stimulation), Huntington's Disease (impaired D1 signaling in striatum), Schizophrenia (altered D1 function in prefrontal cortex), ADHD, Addiction (reward pathway dysregulation)
Apomorphine - D1/D2 agonist used for Parkinson's disease rescue therapy. Bromocriptine and pergolide - dopamine agonists. Levodopa indirectly activates D1 receptors. D1-selective agonists in development for cognitive enhancement in AD. Aplindore and PF-06412562 in clinical trials. D1 antagonists used in schizophrenia but cause parkinsonism.
The study of D1 Dopamine Receptor has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
D1 receptors are widely distributed:
D1 receptors couple to Gs/olf proteins:
Parkinson's Disease:
Alzheimer's Disease:
Huntington's Disease:
D1 Agonists:
Clinical Applications: